Elucidating New Drug Targets in Psoriasis by Gene Profiling: an Opportunity to Be Seized
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Boyman O, Hefti H, Conrad C, Nickoloff B, Suter M, Nestle F
. Spontaneous development of psoriasis in a new animal model shows an essential role for resident T cells and tumor necrosis factor-alpha. J Exp Med. 2004; 199(5):731-6.
PMC: 2213300.
DOI: 10.1084/jem.20031482.
View
2.
Bissonnette R, Papp K, Maari C, Yao Y, Robbie G, White W
. A randomized, double-blind, placebo-controlled, phase I study of MEDI-545, an anti-interferon-alfa monoclonal antibody, in subjects with chronic psoriasis. J Am Acad Dermatol. 2010; 62(3):427-36.
DOI: 10.1016/j.jaad.2009.05.042.
View
3.
Lowes M, Suarez-Farinas M, Krueger J
. Immunology of psoriasis. Annu Rev Immunol. 2014; 32:227-55.
PMC: 4229247.
DOI: 10.1146/annurev-immunol-032713-120225.
View
4.
Noda S, Krueger J, Guttman-Yassky E
. The translational revolution and use of biologics in patients with inflammatory skin diseases. J Allergy Clin Immunol. 2014; 135(2):324-36.
DOI: 10.1016/j.jaci.2014.11.015.
View
5.
Wolk K, Kunz S, Witte E, Friedrich M, Asadullah K, Sabat R
. IL-22 increases the innate immunity of tissues. Immunity. 2004; 21(2):241-54.
DOI: 10.1016/j.immuni.2004.07.007.
View